Skip to main content
Halal FriendlyTakaful direct billing
YILV CHINA logoYILV CHINA
menu_bookProton & heavy ion radiotherapy10 min read•Skull base chordoma / locally advanced prostate

Proton and heavy-ion therapy in Shanghai

AuthorYILV CHINA content and clinical coordination team•Medically reviewed byRadiation physics PhDs — dual review•Published 2025-11-04•Updated 2026-09-17

How carbon-ion dosimetry and the Bragg Peak protect the optic nerve and brainstem, and the assessment thresholds for Malaysian patients going to Shanghai.

Proton and heavy-ion radiotherapy are mentioned repeatedly because of their physical property: energy is released in a concentrated way only once it reaches the intended depth. This property determines their ability to protect nearby vital organs, and also means that not every patient is a suitable candidate. This article explains the practical process for Malaysian patients travelling to Shanghai, from assessment thresholds to scheduling rhythm.

1. What the Bragg peak actually means

Conventional photon radiotherapy is like a highly penetrating beam that releases energy continuously along its path through the body, so normal tissue beyond the target volume also receives dose. Protons and heavy ions are different: the energy is released mainly in a concentrated way once the intended depth is reached, forming what is called the “Bragg peak”.

For patients whose lesions lie immediately next to the optic nerve, brainstem, spinal cord or heart, this difference often determines whether treatment is feasible at all.

2. Which situations are most often assessed

  • Complex lesions of the skull base and within the skull, such as chordoma and some meningiomas
  • Tumours in children and adolescents (a group more sensitive to the long-term risk of second tumours)
  • Locally advanced prostate, liver or lung cancer and similar situations where nearby organs need protection
  • Recurrent lesions that need re-irradiation after previous radiotherapy

Suitability depends on lesion location, size, pathological type and previous treatment history, and must be judged case by case by the radiotherapy team. Publicly available information shows that Shanghai Proton and Heavy Ion Hospital has treated more than 7,000 cases in total and has developed a relatively mature assessment pathway.

3. Assessment process and thresholds

  1. Document submission: pathology slides and immunohistochemistry reports, recent contrast-enhanced imaging (including raw DICOM data), previous radiotherapy records and dosimetry data.
  2. First-round assessment: the radiotherapy department judges whether there is an indication for particle therapy.
  3. Additional tests: localisation CT/MRI and performance status assessment completed in hospital where necessary.
  4. Plan and scheduling: determining the beam type, fractionation schedule and treatment duration.

How complete the documents are directly affects how many rounds of assessment are needed. In practice, cases with complete imaging and dosimetry data are assessed noticeably faster.

4. Treatment duration and travel arrangements

Proton therapy usually requires several consecutive weeks with multiple sessions per week, and is mainly delivered on an outpatient basis. This means families need to arrange accommodation and caregiving for a long stay rather than a short visit.

Step Approximate timing Family preparation
Assessment and localisation Within a few days of arriving at the hospital Bring original pathology and imaging materials
Treatment planning A few days after localisation Confirm the number of fractions with the doctor
Consecutive irradiation Several weeks, multiple sessions per week Stay close to the hospital to reduce commuting
Review After treatment ends Coordinate with the follow-up plan back home

5. Frequently asked questions

Q: Can I have proton therapy after conventional radiotherapy? It can be assessed, but previous dosimetry data is needed to judge how much more dose the normal tissue can tolerate.

Q: Is hospitalisation required during treatment? Most treatment is outpatient; a minority of cases require admission, arranged by the hospital according to the condition.

Q: Does a family member need to accompany the patient throughout? At least one family member is recommended, especially for patients who need language assistance and daily care.

Whether a patient is accepted and which beam type and fractionation schedule is used are determined independently by the hospital’s radiotherapy team. This article does not constitute medical advice.

verified_userReview & scope

Author
YILV CHINA content and clinical coordination team
Clinical review
Radiation physics PhDs — dual review
Review date
2025-11-04
Intended for
Skull base chordoma / locally advanced prostate
Publication date
2025-11-04
Content scope
Cross-border care pathway and document preparation

This column explains the process, documents and compliance points of seeking care in China. It is not advice on diagnosis, medication or insurance claims. Whether a patient is admitted, and which treatment plan is used, is decided independently by the treating physician team of the receiving hospital based on in-person findings.

Not sure whether this applies to you? Start with a free case review

Send your existing Malaysian hospital diagnosis, pathology or imaging files. YILV CHINA will issue a preliminary opinion within 24 hours and tell you whether the case qualifies for green-channel admission at a Chinese Grade 3A hospital.